The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship

被引：34
作者：
Subramanya S.H. [1 ]
Czyż D.M. [2 ]
Acharya K.P. [3 ]
Humphreys H. [4 ,5 ]
机构：
[1] Department of Medical Microbiology, Manipal College of Medical Sciences, Pokhara
[2] Department of Microbiology and Cell Science, University of Florida, Gainesville, FL
[3] Animal Quarantine Office, Budhanilkantha, Kathmandu
[4] Department of Clinical Microbiology, RCSI, Dublin
[5] Department of Microbiology, Beaumont Hospital, Dublin
来源：
VirusDisease | 2021年 / 32卷 / 2期
关键词：
Antibiotics; Antimicrobial resistance; Coronavirus; COVID-19; LMIC;
D O I：
10.1007/s13337-021-00695-2
中图分类号：
学科分类号：
摘要：
The rapid emergence and spread of antimicrobial resistance continue to kill an estimated 700,000 people annually, and this number is projected to increase ten-fold by 2050. With the lack of data, it is uncertain how the COVID-19 pandemic will affect antimicrobial resistance. Severe disruption of research, innovation, global health programs, and compromised antimicrobial stewardship, infection prevention and control programs, especially in low-and middle-income countries, could affect antimicrobial resistance. However, factors such as strict lockdown, social distancing, vaccination, and the extensive implementation of hand hygiene and face masks, with limited international travel and migration, may also contribute to decreasing AMR. Although the impact of COVID-19 on AMR is global, the adverse effect is likely to be worse in LMICs. In this article, we explore the possible impact of the current pandemic on antibiotic resistance. © 2021, Indian Virological Society.
引用
收藏
页码：330 / 337
页数：7
相关论文
共 70 条
[1]  
Ajibola O., Omisakin O.A., Eze A.A., Et al., Self-Medication with Antibiotics, Attitude and Knowledge of Antibiotic Resistance among Community Residents and Undergraduate Students in Northwest Nigeria, Diseases., 6, 2, (2018)
[2]  
Antimicrobial resistance in the age of COVID-19, Nat Microbiol, 5, (2020)
[3]  
Armitage R., Nellums L.B., Antibiotic prescribing in general practice during COVID-19, Lancet Infect Dis, (2020)
[4]  
Barach P., Fisher S.D., Adams M.J., Et al., Disruption of healthcare: Will the COVID pandemic worsen non-COVID outcomes and disease outbreaks?, Prog Pediatr Cardiol, (2020)
[5]  
Bengoechea J.A., Bamford C.G.G., SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?, EMBO Mol Med., 12, 7, (2020)
[6]  
Bengoechea J.A., Sa P.J., Klebsiella pneumoniae infection biology: living to counteract host defences, FEMS Microbiol Rev, 43, 2, pp. 123-144, (2019)
[7]  
Beovic B., Dousak M., Ferreira-Coimbra J., Et al., Antibiotic use in patients with COVID-19: A ‘snapshot’ infectious diseases international research initiative (ID-IRI) survey, J Antimicrob Chemother, 75, (2020)
[8]  
Berndtson A.E., Increasing globalization and the movement of antimicrobial resistance between countries, Surg Infect (Larchmt)., 21, (2020)
[9]  
Biswal M., Kanaujia R., Angrup A., Et al., Disinfection tunnels: potentially counterproductive in the context of a prolonged pandemic of COVID-19, Public Health., 183, (2020)
[10]  
Blanco P., Hernando-Amado S., Reales-Calderon J., Et al., Bacterial multidrug efflux pumps: much more than antibiotic resistance determinants, Microorganisms., 4, (2016)
1234567